ArticleACS pharmacology & translational science2021

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial.

Leticia R Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.